Mechanisms of Action of the p53 Tumor Suppressor and Prospects for Cancer Gene Therapy by Reconstitution of p53 Function
- 1 May 1994
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 716 (1) , 265-282
- https://doi.org/10.1111/j.1749-6632.1994.tb21718.x
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Diversity of human p53 mutants revealed by complex formation to SV40 T antigenEuropean Journal Of Cancer, 1993
- Inhibition of DNA replication factor RPA by p53Nature, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- ras-Induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutationCell, 1992
- Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1Biochemical and Biophysical Research Communications, 1991
- Different Tumor-Derived p53 Mutants Exhibit Distinct Biological ActivitiesScience, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigenCell, 1989
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989